Alzai Health Corp. TSXV Listing

Alzai Health Corporation has announced that it has met all final listing requirements for the TSX Venture Exchange, paving the way for its initial public offering. The offering aims to raise between $3,200,000 and $4,000,000 by selling 8,000,000 to 10,000,000 units at $0.40 each. Meritz Securities is acting as the exclusive agent for the offering and has been granted an option to sell an additional 15% of the units. Each unit includes one common share and one-half of a common share purchase warrant, with warrants exercisable at $0.60 until June 9, 2028. Alzai Health Corporation's common shares are anticipated to be listed on the TSX Venture Exchange on June 8, 2026, under the symbol 'ALZI', with trading expected to commence on June 9, 2026, after a brief halt. Alzai Health Corporation specializes in an AI-driven, non-invasive Alzheimer's Disease risk screening solution.